Press Release Phathom Pharmaceuticals To Present Voquezna® Data At The American College Of Gastroenterology Acg 2024 Annual Meeting
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Press Release Phathom Pharmaceuticals To Present Voquezna® Data At The American College Of Gastroenterology Acg 2024 Annual Meeting is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at the American College of ...
Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced ... Read More
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ... Read More
Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA®
First patient dosed, with topline results expected in 2027pHalcon-EoE-201 is the first large, well-controlled clinical trial of an acid secretory treatment in EoE ... Read More
Phathom Pharmaceuticals Publishes Phase 3 Trial Results
Phathom Pharmaceuticals ( ($PHAT) ) has provided an announcement. On October 25, 2025, Phathom Pharmaceuticals announced the publication of ... Read More
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non ...
Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal reflux disease (GERD) ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus